C4 Therapeutics
Riadh Lobbardi is currently the Director of Translational Medicine at C4 Therapeutics, Inc., with previous experience as a Senior Scientist in Translational Medicine at Blueprint Medicines and as a Research Fellow at Massachusetts General Hospital. Riadh has a background in molecular and cellular developmental biology, with a Ph.D. from Université Pierre et Marie Curie (Paris VI) / Ecole Normale Superieure. Their research interests have focused on investigating molecular mechanisms in cancer and muscle formation, particularly in zebrafish models.
C4 Therapeutics
6 followers
C4 Therapeutics (C4T) is a biopharmaceutical company focused on harnessing the body’s natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.